U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.653G>A (p.Trp218Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003727123.2

Allele description [Variation Report for NM_000372.5(TYR):c.653G>A (p.Trp218Ter)]

NM_000372.5(TYR):c.653G>A (p.Trp218Ter)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.653G>A (p.Trp218Ter)
HGVS:
  • NC_000011.10:g.89178606G>A
  • NG_008748.1:g.5735G>A
  • NM_000372.5:c.653G>AMANE SELECT
  • NP_000363.1:p.Trp218Ter
  • NC_000011.9:g.88911774G>A
Protein change:
W218*
Molecular consequence:
  • NM_000372.5:c.653G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004535557Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 22, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hermansky-Pudlak syndrome genes are frequently mutated in patients with albinism from the Arabian Peninsula.

Khan AO, Tamimi M, Lenzner S, Bolz HJ.

Clin Genet. 2016 Jul;90(1):96-8. doi: 10.1111/cge.12715. Epub 2016 Jan 20. No abstract available.

PubMed [citation]
PMID:
26785811

Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.

Zhong Z, Gu L, Zheng X, Ma N, Wu Z, Duan J, Zhang J, Chen J.

Pigment Cell Melanoma Res. 2019 Sep;32(5):672-686. doi: 10.1111/pcmr.12790. Epub 2019 May 29.

PubMed [citation]
PMID:
31077556
PMCID:
PMC6852118
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004535557.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with clinical features of TYR-related conditions (PMID: 26785811, 31077556). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp218*) in the TYR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYR are known to be pathogenic (PMID: 23504663).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024